That 39% Muscle Loss Number on Ozempic Is Missing Context

About 39% of weight lost on semaglutide is lean body mass. That number from the STEP 1 trial has launched a thousand panicked Instagram posts. But lean body mass is not the same thing as muscle, and the people in that trial were not lifting weights.

The Short Answer

GLP-1 medications do cause lean mass loss, but so does every form of weight loss. The proportion is comparable to dieting alone. Resistance training cuts the lean mass loss ratio roughly in half.

The STEP 1 Numbers Are Real, but Incomplete

The STEP 1 trial enrolled 1961 adults with obesity. Over 68 weeks, the semaglutide group lost 14.9% of their body weight compared to 2.4% with placebo. The lean body mass portion of that loss sat at approximately 39%.

That sounds alarming until you look at what "lean body mass" actually includes. It is not just muscle. DXA scans measure water, organ tissue, bone mineral content, and connective tissue under the same umbrella. When you lose significant weight rapidly, you lose water stored in tissue, glycogen in muscle, and yes, some actual contractile muscle fiber. Lumping all of that together and calling it "muscle loss" misrepresents the data.

The trial also did not mandate any exercise. Participants were not given resistance training protocols or protein targets. The 39% figure reflects what happens when people on GLP-1 medications do nothing beyond taking the drug. That is useful baseline data, but it is not your destiny if you train.

Dieting Without Lifting Produces the Same Ratio

A 2026 meta-analysis in Diabetes, Obesity & Metabolism pooled data from 15782 participants across 20 RCTs. Eisa and Barood found that semaglutide users lost 35.2% of total weight as lean mass (95% CI: 31.5-38.9%). Lifestyle interventions alone, meaning calorie restriction without resistance training, produced a lean mass loss proportion of 26.2%.

Those numbers are closer than the headlines suggest. The gap narrows further when you account for the speed of weight loss on GLP-1 medications versus slower dieting. Rapid weight loss of any kind increases the lean mass proportion because the body has less time to adapt and preferentially burn fat.

The critical finding: lifestyle interventions that included resistance training brought the lean mass loss proportion down to 17.5% (95% CI: 14.2-20.8%). That is less than half the rate seen without lifting. The medication is not the problem. Sitting on the couch while taking it is.

The Decade-of-Aging Comparison

A Diabetes Care review by Locatelli and colleagues framed the typical lean mass loss from incretin therapies at roughly 6 kg, comparable to a decade or more of aging. That framing gets attention for good reason. Losing ten years of lean tissue in a single year of treatment is not trivial.

This comes from a narrative review rather than a controlled trial, so treat it as an estimate rather than a precise measurement. The same review noted that supervised resistance training programs longer than 10 weeks can produce approximately 3 kg of lean mass gain and around 25% strength increase in both men and women.

The math is straightforward. If you are losing 6 kg of lean mass from the medication but gaining 3 kg back through lifting, you have cut your net lean mass loss in half. And that 3 kg figure comes from general resistance training data, not specifically from people on GLP-1 medications training optimally. The actual potential may be higher.

No large RCT has directly studied a structured resistance training program combined with GLP-1 therapy measuring muscle-specific outcomes. Most data comes from weight loss studies that did not include exercise protocols. The evidence is strong enough to act on, but we should be honest about what we do not yet know. The ideal protein intake specifically for GLP-1 users has not been established in controlled trials either.

What to Do If You Are on a GLP-1 Medication

Lift three to four times per week. Full-body or upper-lower splits work well. Prioritize compound movements: squats, deadlifts, rows, presses. These recruit the most muscle mass per session and are the most time-efficient choice when your appetite is suppressed and energy may be lower.

Protein intake matters more on GLP-1 medications because appetite suppression makes eating enough genuinely difficult. Target 1.2 to 1.6 grams per kilogram of body weight daily. Front-load protein at meals when your appetite is highest, typically morning or early afternoon before the medication suppresses hunger in the evening.

If you struggle to hit protein targets through food alone, a protein shake between meals serves as insurance. Not as your primary source, but as a bridge on days when nausea or low appetite makes solid meals difficult.

Track your strength numbers, not just your weight. If your squat and deadlift are holding steady or going up while the scale drops, you are losing fat, not muscle. The scale alone tells you nothing about body composition.

One more thing to watch: if you are losing weight rapidly (more than 1% of body weight per week), talk to your prescribing doctor about adjusting the dose. Slower weight loss preserves more lean tissue regardless of training status.

About Be Fit and Strong Evidence-based fitness coaching for busy professionals in Dubai. Built by Mirza.

Looking for evidence-based coaching that works around your life? See how online coaching works.